{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:38:07Z","timestamp":1791945487677,"version":"4.3.4"},"reference-count":70,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,10,11]]},"abstract":"<jats:p>Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.<\/jats:p>","DOI":"10.1126\/sciadv.aax1532","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T19:25:28Z","timestamp":1571253928000},"source":"Crossref","is-referenced-by-count":234,"title":["The treatment of cocaine use disorder"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-8324","authenticated-orcid":true,"given":"Kyle M.","family":"Kampman","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, Center for Studies of Addiction, University of Pennsylvania, 3535 Market Street, Suite 500, Philadelphia, PA 19104, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_1_2_2","unstructured":"Substance Abuse and Mental Health Services Administration (2018). Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18\u20135068 NSDUH Series H-53) Rockville MD: Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration; https:\/\/www.samhsa.gov\/data\/."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","article-title":"Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses","volume":"180","author":"Butler A. J.","year":"2017","unstructured":"A. J. Butler, J. Rehm, B. Fischer, Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses. Drug Alcohol Depend. 180, 401\u2013416 (2017).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_4_2","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011-2016","volume":"67","author":"Hedegaard H.","year":"2018","unstructured":"H. Hedegaard, B. A. Bastian, J. P. Trinidad, M. Spencer, M. Warner, Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. Natl. Vital Stat. Rep. 67, 1\u201314 (2018).","journal-title":"Natl. Vital Stat. Rep."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1812"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005053-199403000-00005","article-title":"Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation","volume":"182","author":"Alterman A. I.","year":"1994","unstructured":"A. I. Alterman, C. P. O'Brien, A. T. McLellan, D. S. August, E. C. Snider, M. Droba, J. W. Cornish, C. P. Hall, A. H. Raphaelson, F. X. Schrade, Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J. Nerv. Ment. Dis. 182, 157\u2013163 (1994).","journal-title":"J. Nerv. Ment. Dis."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v16n02_02","article-title":"Efficacy of outpatient intensive treatment for drug abuse","volume":"16","author":"Campbell J.","year":"1997","unstructured":"J. Campbell, W. Gabrielli, L. J. Laster, B. I. Liskow, Efficacy of outpatient intensive treatment for drug abuse. J. Addict. Dis. 16, 15\u201325 (1997).","journal-title":"J. Addict. Dis."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1081\/ADA-100101854","article-title":"A retrospective investigation of an intensive outpatient substance abuse treatment program","volume":"25","author":"Fishman J.","year":"1999","unstructured":"J. Fishman, T. Reynolds, E. Riedel, A retrospective investigation of an intensive outpatient substance abuse treatment program. Am. J. Drug Alcohol Abuse 25, 185\u2013196 (1999).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0376-8716(00)00136-8","article-title":"The effectiveness of two intensities of psychosocial treatment for cocaine dependence","volume":"61","author":"Coviello D. M.","year":"2001","unstructured":"D. M. Coviello, A. I. Alterman, M. J. Rutherford, J. S. Cacciola, J. R. McKay, D. A. Zanis, The effectiveness of two intensities of psychosocial treatment for cocaine dependence. Drug Alcohol Depend. 61, 145\u2013154 (2001).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1300\/J069v16n02_05","article-title":"\u201cIntensive\u201d outpatient substance abuse treatment: Comparisons with \u201ctraditional\u201d outpatient treatment","volume":"16","author":"McLellan A. T.","year":"1997","unstructured":"A. T. McLellan, T. A. Hagan, K. Meyers, M. Randall, J. Durell, \u201cIntensive\u201d outpatient substance abuse treatment: Comparisons with \u201ctraditional\u201d outpatient treatment. J. Addict. Dis. 16, 57\u201384 (1997).","journal-title":"J. Addict. Dis."},{"issue":"1","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jsat.2009.12.010","article-title":"Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network","volume":"38","author":"Stitzer M. L.","year":"2010","unstructured":"M. L. Stitzer, N. M. Petry, J. Peirce, Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. J. Subst. Abuse Treat. 38 (suppl. 1) S61\u2013S69 (2010).","journal-title":"J. Subst. Abuse Treat."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archpsyc.59.9.817","article-title":"A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence","volume":"59","author":"Rawson R. A.","year":"2002","unstructured":"R. A. Rawson, A. Huber, M. McCann, S. Shoptaw, D. Farabee, C. Reiber, W. Ling, A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch. Gen. Psychiatry 59, 817\u2013824 (2002).","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins S. T.","year":"1994","unstructured":"S. T. Higgins, A. J. Budney, W. K. Bickel, F. E. Foerg, R. Donham, G. J. Badger, Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 51, 568\u2013576 (1994).","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.1996.01830050045007","article-title":"Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy","volume":"53","author":"Silverman K.","year":"1996","unstructured":"K. Silverman, S. T. Higgins, R. K. Brooner, I. D. Montoya, E. J. Cone, C. R. Schuster, K. L. Preston, Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 53, 409\u2013415 (1996).","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/0022-006X.68.1.64","article-title":"Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up","volume":"68","author":"Higgins S. T.","year":"2000","unstructured":"S. T. Higgins, C. J. Wong, G. J. Badger, D. E. Ogden, R. L. Dantona, Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J. Consult. Clin. Psychol. 68, 64\u201372 (2000).","journal-title":"J. Consult. Clin. Psychol."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1360-0443.2006.01312.x","article-title":"A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals","volume":"101","author":"Rawson R. A.","year":"2006","unstructured":"R. A. Rawson, M. J. McCann, F. Flammino, S. Shoptaw, K. Miotto, C. Reiber, W. Ling, A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 101, 267\u2013274 (2006).","journal-title":"Addiction"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0022-006X.68.2.250","article-title":"Give them prizes, and they will come: Contingency management for treatment of alcohol dependence","volume":"68","author":"Petry N. M.","year":"2000","unstructured":"N. M. Petry, B. Martin, J. L. Cooney, H. R. Kranzler, Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 68, 250\u2013257 (2000).","journal-title":"J. Consult. Clin. Psychol."},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: A meta-analysis","volume":"101","author":"Prendergast M.","year":"2006","unstructured":"M. Prendergast, D. Podus, J. Finney, L. Greenwell, J. Roll, Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 101, 1546\u20131560 (2006).","journal-title":"Addiction"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1176\/appi.ajp.162.8.1452","article-title":"Behavioral therapies for drug abuse","volume":"162","author":"Carroll K. M.","year":"2005","unstructured":"K. M. Carroll, L. S. Onken, Behavioral therapies for drug abuse. Am. J. Psychiatry 162, 1452\u20131460 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1037\/0022-006X.66.5.832","article-title":"Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: Main and matching effects","volume":"66","author":"Maude-Griffin P. M.","year":"1998","unstructured":"P. M. Maude-Griffin, J. M. Hohenstein, G. L. Humfleet, P. M. Reilly, D. J. Tusel, S. M. Hall, Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: Main and matching effects. J. Consult. Clin. Psychol. 66, 832\u2013837 (1998).","journal-title":"J. Consult. Clin. Psychol."},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/j.1360-0443.1997.tb02892.x","article-title":"Brief coping skills treatment for cocaine abuse: Substance use outcomes at three months","volume":"92","author":"Monti P. M.","year":"1997","unstructured":"P. M. Monti, D. J. Rohsenow, E. Michalec, R. A. Martin, D. B. Abrams, Brief coping skills treatment for cocaine abuse: Substance use outcomes at three months. Addiction 92, 1717\u20131728 (1997).","journal-title":"Addiction"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archpsyc.1994.03950120061010","article-title":"One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects","volume":"51","author":"Carroll K. M.","year":"1994","unstructured":"K. M. Carroll, B. J. Rounsaville, C. Nich, L. T. Gordon, P. W. Wirtz, F. Gawin, One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 51, 989\u2013997 (1994).","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1176\/appi.ajp.2008.07111835","article-title":"Computer-assisted delivery of cognitive-behavioral therapy for addiction: A randomized trial of CBT4CBT","volume":"165","author":"Carroll K. M.","year":"2008","unstructured":"K. M. Carroll, S. A. Ball, S. Martino, C. Nich, T. A. Babuscio, K. F. Nuro, M. A. Gordon, G. A. Portnoy, B. J. Rounsaville, Computer-assisted delivery of cognitive-behavioral therapy for addiction: A randomized trial of CBT4CBT. Am. J. Psychiatry 165, 881\u2013888 (2008).","journal-title":"Am. J. Psychiatry"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1176\/appi.ajp.2013.13070987","article-title":"Computer-assisted delivery of cognitive-behavioral therapy: Efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone","volume":"171","author":"Carroll K. M.","year":"2014","unstructured":"K. M. Carroll, B. D. Kiluk, C. Nich, M. A. Gordon, G. A. Portnoy, D. R. Marino, S. A. Ball, Computer-assisted delivery of cognitive-behavioral therapy: Efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am. J. Psychiatry 171, 436\u2013444 (2014).","journal-title":"Am. J. Psychiatry"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"e1002715","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis","volume":"15","author":"De Crescenzo F.","year":"2018","unstructured":"F. De Crescenzo, M. Ciabattini, G. L. D'Al\u00f2, R. De Giorgi, C. Del Giovane, C. Cassar, L. Janiri, N. Clark, M. J. Ostacher, A. Cipriani, Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLOS Med. 15, e1002715 (2018).","journal-title":"PLOS Med."},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman K.","year":"2015","unstructured":"K. Kampman, M. Jarvis, American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J. Addict. Med. 9, 358\u2013367 (2015).","journal-title":"J. Addict. Med."},{"issue":"2","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1520-037X.2007.05963.x","article-title":"Smoking cessation pharmacotherapy\u2014Nicotine and non-nicotine preparations","volume":"10","author":"Frishman W. H.","year":"2007","unstructured":"W. H. Frishman, Smoking cessation pharmacotherapy\u2014Nicotine and non-nicotine preparations. Prev. Cardiol. 10 (2 suppl. 1), 10\u201322 (2007).","journal-title":"Prev. Cardiol."},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMct0800146","article-title":"Varenicline for tobacco dependence","volume":"359","author":"Hays J. T.","year":"2008","unstructured":"J. T. Hays, J. O. Ebbert, Varenicline for tobacco dependence. N. Engl. J. Med. 359, 2018\u20132024 (2008).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial","volume":"21","author":"Grabowski J.","year":"2001","unstructured":"J. Grabowski, H. Rhoades, J. Schmitz, A. Stotts, L. A. Daruzska, D. Creson, F. G. Moeller, Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial. J. Clin. Psychopharmacol. 21, 522\u2013526 (2001).","journal-title":"J. Clin. Psychopharmacol."},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: Two double-blind randomized clinical trials","volume":"29","author":"Grabowski J.","year":"2004","unstructured":"J. Grabowski, H. Rhoades, A. Stotts, K. Cowan, C. Kopecky, A. Dougherty, F. G. Moeller, S. Hassan, J. Schmitz, Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: Two double-blind randomized clinical trials. Neuropsychopharmacology 29, 969\u2013981 (2004).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","article-title":"Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: A randomised, double-blind, placebo-controlled trial","volume":"387","author":"Nuijten M.","year":"2016","unstructured":"M. Nuijten, P. Blanken, B. van de Wetering, B. Nuijen, W. van den Brink, V. M. Hendriks, Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: A randomised, double-blind, placebo-controlled trial. Lancet 387, 2226\u20132234 (2016).","journal-title":"Lancet"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs. placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: A randomized clinical trial","volume":"72","author":"Levin F. R.","year":"2015","unstructured":"F. R. Levin, J. J. Mariani, S. Specker, M. Mooney, A. Mahony, D. J. Brooks, D. Babb, Y. Bai, L. E. Eberly, E. V. Nunes, J. Grabowski, Extended-release mixed amphetamine salts vs. placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: A randomized clinical trial. JAMA Psychiat. 72, 593\u2013602 (2015).","journal-title":"JAMA Psychiat."},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney M. E.","year":"2009","unstructured":"M. E. Mooney, D. V. Herin, J. M. Schmitz, N. Moukaddam, C. E. Green, J. Grabowski, Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 101, 34\u201341 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications","volume":"301","author":"Volkow N. D.","year":"2009","unstructured":"N. D. Volkow, J. S. Fowler, J. Logan, D. Alexoff, W. Zhu, F. Telang, G.-J. Wang, M. Jayne, J. M. Hooker, C. Wong, B. Hubbard, P. Carter, D. Warner, P. King, C. Shea, Y. Xu, L. Muench, K. Apelskog-Torres, Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA 301, 1148\u20131154 (2009).","journal-title":"JAMA"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0169-328X(94)90082-5","article-title":"Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain","volume":"26","author":"Touret M.","year":"1994","unstructured":"M. Touret, M. Sallanon-Moulin, C. Fages, V. Roudier, M. Didier-Bazes, B. Roussel, M. Tardy, M. Jouvet, Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. Brain Res. Mol. Brain Res. 26, 123\u2013128 (1994).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1196\/annals.1300.021","article-title":"Glutamatergic agents for cocaine dependence","volume":"1003","author":"Dackis C.","year":"2003","unstructured":"C. Dackis, C. O'Brien, Glutamatergic agents for cocaine dependence. Ann. N. Y. Acad. Sci. 1003, 328\u2013345 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis C. A.","year":"2003","unstructured":"C. A. Dackis, K. G. Lynch, E. Yu, F. F. Samaha, K. M. Kampman, J. W. Cornish, A. Rowan, S. Poole, L. White, C. P. O'Brien, Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 70, 29\u201337 (2003).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm R.","year":"2006","unstructured":"R. Malcolm, K. Swayngim, J. L. Donovan, C. L. DeVane, A. Elkashef, N. Chiang, R. Khan, J. Mojsiak, D. L. Myrick, S. Hedden, K. Cochran, R. F. Woolson, Modafinil and cocaine interactions. Am. J. Drug Alcohol Abuse 32, 577\u2013587 (2006).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart C. L.","year":"2008","unstructured":"C. L. Hart, M. Haney, S. K. Vosburg, E. Rubin, R. W. Foltin, Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33, 761\u2013768 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","article-title":"Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study","volume":"141","author":"Verrico C. D.","year":"2014","unstructured":"C. D. Verrico, C. N. Haile, J. J. Mahoney III, D. G. Y. Thompson-Lake, T. F. Newton, R. De La Garza II, Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 141, 72\u201378 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis C. A.","year":"2005","unstructured":"C. A. Dackis, K. M. Kampman, K. G. Lynch, H. M. Pettinati, C. P. O'Brien, A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30, 205\u2013211 (2005).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson A. L.","year":"2009","unstructured":"A. L. Anderson, M. S. Reid, S.-H. Li, T. Holmes, L. Shemanski, A. Slee, E. V. Smith, R. Kahn, N. Chiang, F. Vocci, D. Ciraulo, C. Dackis, J. D. Roache, I. M. Salloum, E. Somoza, H. C. Urschel III, A. M. Elkashef, Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 104, 133\u2013139 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman K. M.","year":"2015","unstructured":"K. M. Kampman, K. G. Lynch, H. M. Pettinati, K. Spratt, M. R. Wierzbicki, C. Dackis, C. P. O'Brien, A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend. 155, 105\u2013110 (2015).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis C. A.","year":"2012","unstructured":"C. A. Dackis, K. M. Kampman, K. G. Lynch, J. G. Plebani, H. M. Pettinati, T. Sparkman, C. P. O'Brien, A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J. Subst. Abuse Treat. 43, 303\u2013312 (2012).","journal-title":"J. Subst. Abuse Treat."},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10550490802545174","article-title":"Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment","volume":"18","author":"Ahmadi J.","year":"2009","unstructured":"J. Ahmadi, K. M. Kampman, D. M. Oslin, H. M. Pettinati, C. Dackis, T. Sparkman, Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am. J. Addict. 18, 81\u201386 (2009).","journal-title":"Am. J. Addict."},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/0893-164X.15.1.52","article-title":"Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment","volume":"15","author":"Kampman K. M.","year":"2001","unstructured":"K. M. Kampman, A. I. Alterman, J. R. Volpicelli, I. Maany, E. S. Muller, D. D. Luce, E. M. Mulholland, A. F. Jawad, G. A. Parikh, F. D. Mulvaney, R. M. Weinrieb, C. P. O'Brien, Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol. Addict. Behav. 15, 52\u201359 (2001).","journal-title":"Psychol. Addict. Behav."},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0740-5472(02)00237-4","article-title":"Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures","volume":"23","author":"Patkar A. A.","year":"2002","unstructured":"A. A. Patkar, C. C. Thornton, W. H. Berrettini, E. Gottheil, S. P. Weinstein, K. P. Hill, Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures. J. Subst. Abuse Treat. 23, 33\u201340 (2002).","journal-title":"J. Subst. Abuse Treat."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00952990701199416","article-title":"Treatment outcome predictors for cocaine dependence","volume":"33","author":"Poling J.","year":"2007","unstructured":"J. Poling, T. R. Kosten, M. Sofuoglu, Treatment outcome predictors for cocaine dependence. Am. J. Drug Alcohol Abuse 33, 191\u2013206 (2007).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0269881115582151","article-title":"Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial","volume":"29","author":"Nuijten M.","year":"2015","unstructured":"M. Nuijten, P. Blanken, W. van den Brink, V. Hendriks, Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. J. Psychopharmacol. 29, 678\u2013687 (2015).","journal-title":"J. Psychopharmacol."},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5","article-title":"Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine","volume":"34","author":"Gerasimov M. R.","year":"1999","unstructured":"M. R. Gerasimov, C. R. Ashby Jr., E. L. Gardner, M. J. Mills, J. D. Brodie, S. L. Dewey, Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34, 11\u201319 (1999).","journal-title":"Synapse"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.12-10-03773.1992","article-title":"GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography","volume":"12","author":"Dewey S. L.","year":"1992","unstructured":"S. L. Dewey, G. S. Smith, J. Logan, J. D. Brodie, D. W. Yu, R. A. Ferrieri, P. T. King, R. R. MacGregor, T. P. Martin, A. P. Wolf, GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J. Neurosci. 12, 3773\u20133780 (1992).","journal-title":"J. Neurosci."},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey S. L.","year":"1997","unstructured":"S. L. Dewey, C. S. Chaurasia, C.-E. Chen, N. D. Volkow, F. A. Clarkson, S. P. Porter, R. M. Straughter-Moore, D. L. Alexoff, D. Tedeschi, N. B. Russo, J. S. Fowler, J. D. Brodie, GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25, 393\u2013398 (1997).","journal-title":"Synapse"},{"key":"e_1_3_1_53_2","first-page":"797","article-title":"The irreversible \u03b3-aminobutyric acid (GABA) transaminase inhibitor \u03b3-vinyl-GABA blocks cocaine self-administration in rats","volume":"290","author":"Kushner S. A.","year":"1999","unstructured":"S. A. Kushner, S. L. Dewey, C. Kornetsky, The irreversible \u03b3-aminobutyric acid (GABA) transaminase inhibitor \u03b3-vinyl-GABA blocks cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 290, 797\u2013802 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0893-133X(96)00002-4","article-title":"Baclofen attenuates the reinforcing effects of cocaine in rats","volume":"15","author":"Roberts D. C.","year":"1996","unstructured":"D. C. Roberts, M. M. Andrews, G. J. Vickers, Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15, 417\u2013423 (1996).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.012484"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.2009.05144.x","article-title":"Cocaine-induced neuroadaptations in glutamate transmission: Potential therapeutic targets for craving and addiction","volume":"1187","author":"Schmidt H. D.","year":"2010","unstructured":"H. D. Schmidt, R. C. Pierce, Cocaine-induced neuroadaptations in glutamate transmission: Potential therapeutic targets for craving and addiction. Ann. N. Y. Acad. Sci. 1187, 35\u201375 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.51.2.627","article-title":"Topiramate increases cerebral GABA in healthy humans","volume":"51","author":"Kuzniecky R.","year":"1998","unstructured":"R. Kuzniecky, H. Hetherington, S. Ho, J. Pan, R. Martin, F. Gilliam, J. Hugg, E. Faught, Topiramate increases cerebral GABA in healthy humans. Neurology 51, 627\u2013629 (1998).","journal-title":"Neurology"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.52.3.473","article-title":"Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy","volume":"52","author":"Petroff O. A. C.","year":"1999","unstructured":"O. A. C. Petroff, F. Hyder, R. H. Mattson, D. L. Rothman, Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 52, 473\u2013478 (1999).","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","article-title":"Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons","volume":"41","author":"Gibbs J. W.","year":"2000","unstructured":"J. W. Gibbs III, S. Sombati, R. J. DeLorenzo, D. A. Coulter, Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (suppl. 1), S10\u2013SS6 (2000).","journal-title":"Epilepsia"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman K. M.","year":"2004","unstructured":"K. M. Kampman, H. Pettinati, K. G. Lynch, C. Dackis, T. Sparkman, C. Weigley, C. P. O'Brien, A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 75, 233\u2013240 (2004).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","article-title":"A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence","volume":"133","author":"Kampman K. M.","year":"2013","unstructured":"K. M. Kampman, H. M. Pettinati, K. G. Lynch, K. Spratt, M. R. Wierzbicki, C. P. O'Brien, A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend. 133, 94\u201399 (2013).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction: A randomized clinical trial","volume":"70","author":"Johnson B. A.","year":"2013","unstructured":"B. A. Johnson, N. Ait-Daoud, X.-Q. Wang, J. K. Penberthy, M. A. Javors, C. Seneviratne, L. Liu, Topiramate for the treatment of cocaine addiction: A randomized clinical trial. JAMA Psychiat. 70, 1338\u20131346 (2013).","journal-title":"JAMA Psychiat."},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4088\/JCP.14m09377","article-title":"Efficacy of topiramate in the treatment of crack cocaine dependence: A double-blind, randomized, placebo-controlled trial","volume":"77","author":"Balda\u00e7ara L.","year":"2016","unstructured":"L. Balda\u00e7ara, H. Cogo-Moreira, B. L. Parreira, T. A. Diniz, J. J. Milhomem, C. C. Fernandes, A. L. Lacerda, Efficacy of topiramate in the treatment of crack cocaine dependence: A double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry 77, 398\u2013406 (2016).","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.03.033","article-title":"Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial","volume":"140","author":"Umbricht A.","year":"2014","unstructured":"A. Umbricht, A. DeFulio, E. L. Winstanley, D. A. Tompkins, J. Peirce, M. Z. Mintzer, E. C. Strain, G. E. Bigelow, Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial. Drug Alcohol Depend. 140, 92\u2013100 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_66_2","first-page":"1345","article-title":"Topiramate for the treatment of dually dependent on opiates and cocaine: A single-center placebo-controlled trial","volume":"47","author":"Pirnia B.","year":"2018","unstructured":"B. Pirnia, A. A. Soleimani, P. Malekanmehr, K. Pirnia, A. Zahiroddin, Topiramate for the treatment of dually dependent on opiates and cocaine: A single-center placebo-controlled trial. Iran. J. Public Health 47, 1345\u20131353 (2018).","journal-title":"Iran. J. Public Health"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2014.02.024","article-title":"Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in The Netherlands","volume":"138","author":"Nuijten M.","year":"2014","unstructured":"M. Nuijten, P. Blanken, W. van den Brink, V. Hendriks, Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in The Netherlands. Drug Alcohol Depend. 138, 177\u2013184 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","article-title":"Extended-release mixed amphetamine salts and topiramate for cocaine dependence: A randomized controlled trial","volume":"72","author":"Mariani J. J.","year":"2012","unstructured":"J. J. Mariani, M. Pavlicova, A. Bisaga, E. V. Nunes, D. J. Brooks, F. R. Levin, Extended-release mixed amphetamine salts and topiramate for cocaine dependence: A randomized controlled trial. Biol. Psychiatry 72, 950\u2013956 (2012).","journal-title":"Biol. Psychiatry"},{"key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","article-title":"The role of acetylcholine in cocaine addiction","volume":"33","author":"Williams M. J.","year":"2008","unstructured":"M. J. Williams, B. Adinoff, The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33, 1779\u20131797 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1521-0391.2011.00130.x","article-title":"Effects of galantamine on cocaine use in chronic cocaine users","volume":"20","author":"Sofuoglu M.","year":"2011","unstructured":"M. Sofuoglu, K. M. Carroll, Effects of galantamine on cocaine use in chronic cocaine users. Am. J. Addict. 20, 302\u2013303 (2011).","journal-title":"Am. J. Addict."},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"17m11669","DOI":"10.4088\/JCP.17m11669","article-title":"Galantamine and computerized cognitive behavioral therapy for cocaine cependence: A randomized clinical trial","volume":"79","author":"Carroll K. M.","year":"2018","unstructured":"K. M. Carroll, C. Nich, E. E. DeVito, J. M. Shi, M. Sofuoglu, Galantamine and computerized cognitive behavioral therapy for cocaine cependence: A randomized clinical trial. J. Clin. Psychiatry 79, 17m11669 (2018).","journal-title":"J. Clin. Psychiatry"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aax1532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:22:58Z","timestamp":1704802978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aax1532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,11]]}},"alternative-id":["10.1126\/sciadv.aax1532"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aax1532","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"article-number":"eaax1532"}}